Last reviewed · How we verify

Tamsulosine Arrow LP

Pierre Fabre Medicament · FDA-approved active Small molecule

Tamsulosine Arrow LP is a Alpha-1A adrenergic receptor antagonist Small molecule drug developed by Pierre Fabre Medicament. It is currently FDA-approved for Benign prostatic hyperplasia with lower urinary tract symptoms.

Tamsulosin is an alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow.

Tamsulosin is an alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow. Used for Benign prostatic hyperplasia with lower urinary tract symptoms.

At a glance

Generic nameTamsulosine Arrow LP
SponsorPierre Fabre Medicament
Drug classAlpha-1A adrenergic receptor antagonist
TargetAlpha-1A adrenergic receptor
ModalitySmall molecule
Therapeutic areaUrology
PhaseFDA-approved

Mechanism of action

Tamsulosin selectively blocks alpha-1A adrenergic receptors located on smooth muscle cells in the prostate gland and bladder neck. By antagonizing these receptors, it reduces smooth muscle tone and tension in these tissues, thereby decreasing urinary obstruction and improving urinary symptoms associated with benign prostatic hyperplasia. The LP (long-acting) formulation provides sustained drug release for once-daily dosing.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tamsulosine Arrow LP

What is Tamsulosine Arrow LP?

Tamsulosine Arrow LP is a Alpha-1A adrenergic receptor antagonist drug developed by Pierre Fabre Medicament, indicated for Benign prostatic hyperplasia with lower urinary tract symptoms.

How does Tamsulosine Arrow LP work?

Tamsulosin is an alpha-1A adrenergic receptor antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow.

What is Tamsulosine Arrow LP used for?

Tamsulosine Arrow LP is indicated for Benign prostatic hyperplasia with lower urinary tract symptoms.

Who makes Tamsulosine Arrow LP?

Tamsulosine Arrow LP is developed and marketed by Pierre Fabre Medicament (see full Pierre Fabre Medicament pipeline at /company/pierre-fabre-medicament).

What drug class is Tamsulosine Arrow LP in?

Tamsulosine Arrow LP belongs to the Alpha-1A adrenergic receptor antagonist class. See all Alpha-1A adrenergic receptor antagonist drugs at /class/alpha-1a-adrenergic-receptor-antagonist.

What development phase is Tamsulosine Arrow LP in?

Tamsulosine Arrow LP is FDA-approved (marketed).

What are the side effects of Tamsulosine Arrow LP?

Common side effects of Tamsulosine Arrow LP include Retrograde ejaculation, Dizziness, Headache, Asthenia/fatigue, Orthostatic hypotension.

What does Tamsulosine Arrow LP target?

Tamsulosine Arrow LP targets Alpha-1A adrenergic receptor and is a Alpha-1A adrenergic receptor antagonist.

Related